Live and On-Demand Activities

Filter Activities

Clear

Secondary AML Through the Microscope: A Pathology-informed Guide to Modern Diagnostic and Treatment Principles

0.50 hr(s) | ABIM , ABPath , CC , CME , MOC

Specialty: AML

Therapeutic Area(s): Hematology, Malignant , Oncology

Release Date: September 20, 2021

Expiration Date: September 19, 2022

Location: Internet Activity Enduring

In this activity, an expert pathologist discusses secondary acute myeloid leukemia (AML) as well as the modern tools used in diagnostic assessment that can help facilitate appropriate risk stratification and collaborative treatment decisions so therapies beyond conventional chemotherapy options can be considered.

Visualizing the Present and Future of CLL: How Innovative Therapies and State-of-the-Art Combinations are Transforming Patient Care

0.50 hr(s) | CME

Specialty: Chronic Lymphocytic Leukemia (CLL)

Therapeutic Area(s): Chronic Lympoblastic Leukemia (CLL) , Hematology, Malignant , Oncology

Release Date: September 7, 2021

Expiration Date: September 6, 2022

Location: Internet Activity Enduring

Modern management of chronic lymphocytic leukemia (CLL) has been transformed by innovative therapeutics, including BTK and BCL-2 inhibitors, in a range of patient populations and treatment settings—but what is the next step? In this activity, an expert clinician addresses that question and reviews evidence on emerging targeted options and novel combination strategies likely to affect patient care.

A Personalized Approach to Guide Risk-Adapted Treatment Decisions in Myelofibrosis: Applying the Latest Clinical Evidence on JAK Inhibitors and Novel Combination Therapies to Improve Patient Outcomes

0.50 hr(s) | ABIM , CME , MOC , Royal College of Physicians and Surgeons of Canada

Specialty: Myelofibrosis

Therapeutic Area(s): Oncology

Release Date: August 25, 2021

Expiration Date: August 24, 2022

Location: Internet Activity Enduring

In this activity, hematology-oncology experts discuss the current and emerging therapeutic options for the management of patients with myelofibrosis.

Taking the Fight to AML: Oncology Nurse Perspectives, Principles, and Practice in an Era of Innovative Therapies

1.00 hr(s) | ILNA , NCPD

Specialty: AML

Release Date: August 18, 2021

Expiration Date: August 17, 2022

Location: Internet Activity Enduring

In this activity, two expert nurse panelists use case-based teaching to illustrate solutions to clinical challenges associated with nursing care in the modern acute myeloid leukemia (AML) treatment landscape in which innovative therapies (including targeted agents, newer cytotoxics, and epigenetic approaches) are now core patient treatment strategies.

Taking Aim at the TYK2 Pathway in Psoriasis Addressing Unmet Treatment & Patient Needs With an Innovative Therapeutic Approach

1.00 hr(s) | CME

Specialty: Psoriasis

Therapeutic Area(s): Dermatology

Release Date: September 17, 2021

Expiration Date: September 16, 2021

Location: Internet Activity Enduring

This activity will examine the burden of disease and unmet needs experienced by patients with moderate to severe psoriasis, focusing on the rationale for targeting TYK2 as a treatment approach. In addition, the expert faculty will explore novel TYK2 inhibitors for the treatment of psoriasis in the context of selectivity, efficacy, and safety, as well as their potential clinical use in the context of current evidence and expert recommendations.

Determining Which Patients Will Benefit from GLP-1 RAs: Applying Guidelines and Evidence to Individualize Treatment Decisions in T2DM

0.50 hr(s) | CME

Specialty: Diabetes

Therapeutic Area(s): Endocrinology

Release Date: July 16, 2021

Expiration Date: July 15, 2022

Location: Internet Activity Enduring

In this activity, an expert on type 2 diabetes mellitus (T2DM) discusses how GLP-1 RAs can be integrated into individualized treatment plans to improve outcomes for patients with T2DM.

Demystifying the Role of Incretin-Based Weight Loss Pharmacotherapy: A Patient-Centered Approach to Overcoming Barriers and Addressing Underlying Causes of Obesity

0.500 hr(s) | CME

Therapeutic Area(s): Endocrinology

Release Date: July 15, 2021

Expiration Date: July 14, 2022

Location: Internet Activity Enduring

In this animated activity, an expert in obesity reviews current evidence for incretin-based weight-loss pharmacotherapy and offers evidence-based approaches to individualizing care for patients with obesity.

1 2 3 14
Copy link
Powered by Social Snap